E. Mark Haacke, Ph.D.Top StoriesMRIPI-RADS v2.1 is 'highly sensitive' for prostate cancer detection on MRIPI-RADS v2.1 shows high sensitivity for categorizing clinically significant prostate cancer on MRI at both the patient and lesion levels, German researchers have found.CTBreast CT gains clinical momentum in EuropeCTBelgian study shows AI's promise in coronary ischemiaArtificial IntelligenceAI on the Aegean: EuSoMII congress comes to CreteDigital X-RayAI fracture detection tools tested head-to-head